aerovatetx.com (JBIO): Qarzning balans kapitallashuviga nisbati
Aerovate Therapeutics Inc (JBIO) noyob o'pka kasalliklariga qarshi kurashish uchun olimlarni birlashtirib, ularga RSUlar va ilmiy erkinlikni taklif etadi. Biznes inhalatsiya terapiyalarini ishlab chiqishga tayanadi va daromad mavjud bo'lmagan holatda, u 0.00 miqdorida qayd etilgan, kapitalni tadqiqot va ishlanmalarga (R&D) yo'naltiradi. GURU.Markets platformasidagi aksiya narxi tarixi muvaffaqiyati iqtisodiy sikl bosqichlaridan ko'ra dori vositalarining samaradorligiga bog'liq bo'lgan aktiv dinamikasini aks ettiradi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_JBIO_-_Aerovate-Therapeutics-Inc_-_Debt-to-Net-Assets-Ratio "JBIO: Aerovate Therapeutics, Inc. Qarzning balans kapitallashuviga nisbati 30.04.2025 - 31.10.2026 | 👁️GURU.Markets👁️")
aerovatetx.com (JBIO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aerovate Therapeutics Inc|JBIO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Aerovate Therapeutics|JBIO - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati JBIO|JBIO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Aerovate Therapeutics Inc|Tezkor likvidlik ko‘rsatkichi aerovatetx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:JBIO (Aerovate)
Uzoq muddatli pozitsiyani shakllantirishda xatarlarni minimallashtirish uchun umumiy majburiyatlarning kapitalga nisbatini baholash juda muhimdir. Qarzning kapitalga qoplash koeffitsiyentini tahlil qilish orqali investor Aerovate Therapeutics Inc (JBIO) kompaniyasining o'zining o'pka arterial gipertenziyasi dori vositasini haddan tashqari qarz olmay ishlab chiqishni moliyalashtirish qobiliyatini aniqlaydi, bunda koeffitsiyentning kamayishi FDA tasdig'i oldidan kompaniyaning moliyaviy barqarorligi ortib borayotganini tasdiqlaydi.
Aerovate Therapeutics Inc (JBIO) raqobatchilari
Balans kapitallashuviga qarzlar ARGX (argenx SE)|Balans kapitallashuviga qarzlar biontech.de BNTX|ABVX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADMA (ADMA Biologics Inc)|Protagonist Therapeutics Inc (PTGX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com|Qarzning balans qiymatiga nisbati ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AUPH (Aurinia Pharma)|Sof aktivlarga qarzlar BioCryst Corp (BCRX)|VERA - Qarzning balans kapitallashuviga nisbati|dianthustx.com (DNTH) - Qarzning balans qiymatiga nisbati|Pharvaris (PHVS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|Qarzning balans qiymatiga nisbati TRML|Balans kapitallashuviga qarzlar Precigen Corp|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. (PHAR)|nektar.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UPB (Upstream Bio)|Zenas Bio (ZBIO) - Balans qiymatiga qarzlar|Immunome Corp - Balans kapitallashuviga qarzlar|GOSS - Balans kapitallashuviga qarzlar|KALV: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar septerna.com (SEPN)|Qarzning balans kapitallashuviga nisbati Pieris Pharmaceuticals, Inc.|SVRA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|ANAB - Balans qiymatiga qarzlar|Astria Therapeutics - Qarzning balans qiymatiga nisbati|engene.com - Qarzning balans kapitallashuviga nisbati|RAPT Therapeutics, Inc. - Balans kapitallashuviga qarzlar|ACRS - Balans kapitallashuviga qarzlar|KYTX (Kyverna) - Qarzning balans qiymatiga nisbati|TLSA: Qarzning balans kapitaliga nisbati|CABA (Cabaletta Bio, Inc.) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar ventyxbio.com VTYX|Qarzning balans qiymatiga nisbati THTX (Theratechnologies)|AVTX (Avalo Therapeutics, Inc.) - Qarzning sof aktivlarga nisbati|Eledon - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati AGEN (Agenus, Inc)|Climb Bio Inc - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati ZURA (Zura Bio Ltd)|ATYR: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Adagene Inc. (ADAG)|Qarzning balans kapitallashuviga nisbati ImageneBio|STTK: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar EQ|Balans kapitallashuviga qarzlar connectbiopharm.com (CNTB)|Qarzning balans kapitallashuviga nisbati Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Qarzlarning balans kapitallashuviga nisbati|InflaRx GmbH - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar X4 Pharmaceuticals, Inc|ACET (adicetbio.com) - Qarzning balans qiymatiga nisbati|Celularity (CELU) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati INMB|BRNS (Barinthus Biotherapeutics PLC) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar KZR|Sof aktivlarga qarzlar SAB Biotherapeutics Inc|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|ENLV - Qarzning balans qiymatiga nisbati|QTTB - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar GeoVax Labs GOVX|EDSA (Edesa) - Qarzning balans qiymatiga nisbati|iBio Corporation - Qarzning sof aktivlarga nisbati|CARM (Carisma Therapeutics Inc) - Balans kapitallashuviga qarzlar|xtlbio.com (XTLB) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar APVO (Aptevo Therapeutics Inc.)|AIM - Qarzning balans qiymatiga nisbati|ADTX - Qarzning balans kapitallashuviga nisbati|gribio.com - Qarzning balans kapitaliga nisbati|XRTX: Balans kapitallashuviga qarzlar|HIND (Vyome Holdings Inc.) - Qarzning balans kapitallashuviga nisbati|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Indaptus Corp (INDP) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Scinai Immunotherapeutics (SCNI)|CALI - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Affimed N.V. AFMD|ALLK (Allakos Inc) - Qarzlarning balans kapitallashuviga nisbati|HOOKIPA - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati IGMS (IGM Biosciences, Inc.)|ITOS: Balans kapitallashuviga qarzlar|oceanbiomedical.com (OCEA) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati TC BioPharm|THRD: Qarzning sof aktivlarga nisbati